Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair

Purpose

The growth phases of medically treated abdominal aortic aneurysms (AAA) are frequently associated with an ¹⁸F–fluorodesoxyglucose positron emission tomography (FDG-PET) pattern involving low baseline and subsequent higher FDG uptake. However, the FDG-PET patterns associated with the endovascular aneurysm repair (EVAR) of larger AAA are presently unknown. This study aimed to investigate the relationship between serial AAA FDG uptake measurements, obtained before EVAR and 1 and 6 months post-intervention and subsequent sac shrinkage at 6 months, a well-recognized indicator of successful repair.

Methods

Thirty-three AAA patients referred for EVAR (maximal diameter: 55.4?±?6.0 mm, total volume: 205.7?±?63.0 mL) underwent FDG-PET/computed tomography (CT) before EVAR and at 1 and 6 months thereafter, with the monitoring of AAA volume and of a maximal standardized FDG uptake [SUVmax] averaged between the axial slices encompassing the AAA.

Results

Sac shrinkage was highly variable and could be stratified into three terciles: a first tercile in which shrinkage was absent or very limited (0–29 mL) and a third tercile with pronounced shrinkage (56–165 mL). SUVmax values were relatively low at baseline in the 1st tercile (SUVmax: 1.69?±?0.33), but markedly increased at 6 months (2.42?±?0.69, p?=?0.02 vs. baseline). These SUV max values were by contrast much higher at baseline in the 3rd tercile (SUVmax: 2.53?±?0.83 p?=?0.009 vs. 1st tercile) and stable at 6 months (2.49?±?0.80), while intermediate results were documented in the 2nd tercile. Lastly, the amount of sac shrinkage, expressed in absolute values or in percentages of baseline AAA volumes, was positively correlated with baseline SUVmax (p?=?0.001 for both).

Conclusion

A low pre-EVAR FDG uptake and increased AAA FDG uptake at 6 months are associated with reduced sac shrinkage. This sequential FDG-PET pattern is similar to that already shown to accompany growth phases of medically treated AAA.

     

Intravoxel incoherent motion model-based liver lesion characterisation from three b-value diffusion-weighted MRI

Objective

To evaluate intravoxel incoherent motion (IVIM) model-based liver lesion characterisation from three b-value diffusion-weighted imaging (DWI).

Methods

The 1.5-T DWI data from a respiratory gated spin-echo echo-planar magnetic resonance imaging sequence (b?=?0, 50, 800 s/mm²) were retrospectively analysed in 38 patients with different liver lesions. Conventional apparent diffusion coefficient ADC?=?ADC(0,800) as well as IVIM-based parameters D′?=?ADC(50,800), ADC_low?=?ADC(0,50), and f′ were calculated voxel-wise. Sixty-one regions of interest in hepatocellular carcinomas (HCCs, n?=?24), haemangiomas (HEMs, n?=?11), focal nodular hyperplasias (FNHs, n?=?11), and healthy liver tissue (REFs, n?=?15) were analysed. Group differences were investigated using Student’s t-test and receiver-operating characteristic (ROC) analysis.

Results

Mean values?±?standard deviations of ADC, D′, ADC_low (in 10^-5 mm²/s), and f′ (in %) for REFs/FNHs/HEMs/HCCs were 130?±?11/143?±?27/168?±?16/113?±?25, 104?±?12/123?±?25/162?±?18/102?±?23, 518?±?66/437?±?97/268?±?69/283?±?120, and 18?±?3/14?±?4/6?±?3/9?±?5, respectively. Differences between lesions and REFs were more significant for IVIM-based parameters than for conventional ADC. ROC analysis showed the best discriminability between HCCs and FNHs for ADC_low and f′ and between HEMs and FNHs or HCCs for D′.

Conclusion

Three instead of two b-value DWI enables a numerically stable and voxel-wise IVIM-based analysis for improved liver lesion characterisation with tolerable acquisition time.

Key Points

? Quantitative analysis of diffusion-weighted MRI helps liver lesion characterisation. ? Analysis of intravoxel incoherent motion is superior to apparent diffusion coefficient determination. ? Only three b-values enable separation of diffusion and microcirculation effects. ? The method presented is numerically stable, with voxel-wise results and short acquisition times.     

What parameters from 18F-FDG PET/CT are useful in evaluation of adrenal lesions?

Purpose

Prior studies have suggested that ¹⁸F-FDG PET/CT can help characterize adrenal lesions and differentiate adrenal metastases from benign lesions. The aim of this study was to assess the value of ¹⁸F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions.

Methods

This retrospective study included 85 patients (47 men and 38 women, age 63.8?±?10.8 years) who had undergone ¹⁸F-FDG PET/CT (60 min after injection 300 – 370 MBq ¹⁸F-FDG; Biograph 64 scanner) for evaluation of 102 nonsecreting adrenal masses. For semiquantitative analysis, the maximum standardized uptake value (SUVmax), adrenal to liver (T/L) SUVmax ratio, mean CT attenuation value and tumour diameter were measured in all lesions and compared with the pathological findings.

Results

Malignant adrenal tumours (68 % of evaluated tumours) had a significantly higher mean SUVmax (13.0?±?7.1 vs. 3.7?±?3.0), a higher T/L SUVmax ratio (4.2?±?2.6 vs. 1.0?±?0.9), a higher CT attenuation value (31.9?±?16. 7 HU vs. 0.2?±?25.8 HU) and a greater diameter (43.6?±?23.7 mm vs. 25.6?±?13.3 mm) than benign lesions. The false-positive findings were tuberculosis and benign phaeochromocytoma. Based on ROC analysis, a T/L SUVmax ratio >1.53, an adrenal SUVmax >5.2, an attenuation value >24 HU and a tumour diameter >30 mm were chosen as the optimal cut-off values for differentiating malignant from benign tumours. The areas under the ROC curves for the selected cut-off values were 0.96, 0.96, 0.88 and 0.77, respectively. A multivariate logistic regression model revealed that the T/L SUVmax ratio was an independent prognostic factor for malignancy (p?25 HU and a tumour diameter >30 mm had no additional individual importance in the diagnosis of malignancy.

Conclusion

Using a T/L SUVmax ratio >1.53 and an adrenal SUVmax >5.2 in ¹⁸F-FDG PET/CT led to high diagnostic sensitivity, specificity and negative predictive value for characterizing adrenal tumours. The diagnostic accuracies of the two parameters were comparable, but T/L SUVmax ratio was an independent predictor of malignancy.     

Application of the diffusion kurtosis model for the study of breast lesions

Objectives

To evaluate diffusion-weighted imaging (DWI) and diffusion kurtosis imaging (DKI) in the differentiation and characterisation of breast lesions.

Methods

Thirty-six women underwent breast magnetic resonance imaging (MRI) including a DWI sequence with multiple b-values (50–3,000 s/mm²). Mean values for apparent diffusion coefficient (ADC), mean diffusivity (MD) and mean kurtosis (MK) were calculated by lesion type and histological subtype. Differences and correlation between parameters were determined.

Results

Forty-four lesions were found. There were significant differences between benign and malignant lesions for all parameters (ADC, p?=?0.017; MD, p?=?0.028; MK, p?=?0.017). ADC and MD were higher for benign (1.96?±?0.41?×?10^?3 and 2.17?±?0.42?×?10^?3 mm²/s, respectively) than for malignant lesions (1.33?±?0.18?×?10^?3 and 1.52?±?0.50?×?10^?3 mm²/s). MK was higher for malignant (0.61?±?0.27) than benign lesions (0.37?±?0.18). We found differences between invasive ductal carcinoma (IDC) and fibroadenoma (FA) for all parameters (ADC, MD and MK): p?=?0.016, 0.022 and 0.016, respectively. FA and fibrocystic change (FC) showed differences only in MK (p?=?0.016).

Conclusions

Diffusion in breast lesions follows a non-Gaussian distribution. MK enables differentiation and characterisation of breast lesions, providing new insights into microstructural complexity. To confirm these results, further investigation in a broader sample should be performed.

Key Points

? The diffusion kurtosis model provides new information regarding breast lesions ? MD and MK are valid parameters to characterise tissue microstructure ? MK enables improved lesion differentiation ? MK is able to differentiate lesions that display similar ADC values     

Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI

Introduction

This study seeks to evaluate the diagnostic accuracy of cerebral perfusion imaging with arterial spin labelling (ASL) MR imaging in children with moyamoya disease compared to dynamic susceptibility contrast (DSC) imaging.

Methods

Ten children (7 females; age, 9.2?±?5.4 years) with moyamoya disease underwent cerebral perfusion imaging with ASL and DSC on a 3-T MRI scanner in the same session. Cerebral perfusion images were acquired with ASL (pulsed continuous 3D ASL sequence, 32 axial slices, TR?=?5.5 s, TE?=?25 ms, FOV?=?24 cm, matrix?=?128?×?128) and DSC (gradient echo EPI sequence, 35 volumes of 28 axial slices, TR?=?2,000 ms, TE?=?36 ms, FOV?=?24 cm, matrix?=?96?×?96, 0.2 ml/kg Gd-DOTA). Cerebral blood flow maps were generated. ASL and DSC images were qualitatively assessed regarding perfusion of left and right ACA, MCA, and PCA territories by two independent readers using a 3-point-Likert scale and quantitative relative cerebral blood flow (rCBF) was calculated. Correlation between ASL and DSC for qualitative and quantitative assessment and the accuracy of ASL for the detection of reduced perfusion per territory with DSC serving as the standard of reference were calculated.

Results

With a good interreader agreement (κ?=?0.62) qualitative perfusion assessment with ASL and DSC showed a strong and significant correlation (ρ?=?0.77; p?<?0.001), as did quantitative rCBF (r?=?0.79; p?<?0.001). ASL showed a sensitivity, specificity and accuracy of 94 %, 93 %, and 93 % for the detection of reduced perfusion per territory.

Conclusion

In children with moyamoya disease, unenhanced ASL enables the detection of reduced perfusion per vascular territory with a good accuracy compared to contrast-enhanced DSC.     

Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability,agreement and variability

Objectives

To determine inter-observer and inter-examination variability for aortic valve calcification (AVC) and mitral valve and annulus calcification (MC) in low-dose unenhanced ungated lung cancer screening chest computed tomography (CT).

Methods

We included 578 lung cancer screening trial participants who were examined by CT twice within 3 months to follow indeterminate pulmonary nodules. On these CTs, AVC and MC were measured in cubic millimetres. One hundred CTs were examined by five observers to determine the inter-observer variability. Reliability was assessed by kappa statistics (κ) and intra-class correlation coefficients (ICCs). Variability was expressed as the mean difference ± standard deviation (SD).

Results

Inter-examination reliability was excellent for AVC (κ?=?0.94, ICC?=?0.96) and MC (κ?=?0.95, ICC?=?0.90). Inter-examination variability was 12.7?±?118.2 mm³ for AVC and 31.5?±?219.2 mm³ for MC. Inter-observer reliability ranged from κ?=?0.68 to κ?=?0.92 for AVC and from κ?=?0.20 to κ?=?0.66 for MC. Inter-observer ICC was 0.94 for AVC and ranged from 0.56 to 0.97 for MC. Inter-observer variability ranged from -30.5?±?252.0 mm³ to 84.0?±?240.5 mm³ for AVC and from -95.2?±?210.0 mm³ to 303.7?±?501.6 mm³ for MC.

Conclusions

AVC can be quantified with excellent reliability on ungated unenhanced low-dose chest CT, but manual detection of MC can be subject to substantial inter-observer variability. Lung cancer screening CT may be used for detection and quantification of cardiac valve calcifications.

Key points

? Low-dose unenhanced ungated chest computed tomography can detect cardiac valve calcifications. ? However, calcified cardiac valves are not reported by most radiologists. ? Inter-observer and inter-examination variability of aortic valve calcifications is sufficient for longitudinal studies. ? Volumetric measurement variability of mitral valve and annulus calcifications is substantial.     

Multiple antiplatelet therapy contributes to the reversible high signal spots on diffusion-weighted imaging in elective coiling of unruptured cerebral aneurysm

Introduction

Our aim was to systematically investigate radiographic characteristics and outcome of diffusion-weighted imaging (DWI) changes in the elective coiling of unruptured cerebral aneurysm with analyzing the correlation of antiplatelet therapy (APT).

Methods

In a total of 34 consecutive patients with unruptured cerebral aneurysms initially treated by coiling without stent assist, 26 (76.5 %) had DWI changes with 91 high signal spots within 24–48 h after the procedure. We recorded DWI parameters (location, volume, mean, and minimum values of the apparent diffusion coefficient: expressed as ADC_AVE and ADC_MIN) for each lesion, and evaluated its radiographic outcome on conventional MRI at follow-up (interval, 58.4?±?37.2 days) in the modes of APT.

Results

All patients with DWI high spots had no clinical symptoms. There was a strong correlation between ADC_AVE and ADC_MIN (r?=?0.82, p?<?0.0001). The mean ADC_AVE and rADC_AVE were 0.74?±?0.14?×?10^?3?mm²/s and 87?±?10 %. DWI high spots were small with a mean volume of 0.13?±?0.12 cm³, ranging from 0.04 to 0.86 cm³. A negative correlation was observed between the volume and values of ADC_AVE (r?=??0.48, p?<?0.0001). The DWI volume was significantly larger in single APT than in multiple (0.15?±?0.14 versus 0.10?±?0.07 cm³, p?=?0.0091). The permanent signal change was more observed in single APT than in multiple (24.5 % versus 5.2 %, p?=?0.02).

Conclusion

DWI high spots after elective coiling were small without significant decrease of ADC, and do not correspond to brain infarction. Periprocedural use of multiple antiplatelet agents is expected to reduce the volume of thromboembolism and permanent tissue damages.     

Diffusion-weighted imaging of focal renal lesions: a meta-analysis

Objectives

Contrast-enhanced MRI can only distinguish to a limited extent between malignant and benign focal renal lesions. The aim of this meta-analysis is to review renal diffusion-weighted imaging (DWI) to compare apparent diffusion coefficient (ADC) values for different renal lesions that can be applied in clinical practice.

Methods

A PubMed search was performed to identify relevant articles published 2004–2011 on renal DWI of focal renal lesions. ADC values were extracted by lesion type to determine whether benign or malignant. The data table was finalised in a consensus read. ADC values were evaluated statistically using meta-regression based on a linear mixed model. Two-sided P value <5 % indicated statistical significance.

Results

The meta-analysis is based on 17 studies with 764 patients. Renal cell carcinomas have significant lower ADC values than benign tissue (1.61?±?0.08?×?10^-3 mm²/s vs 2.10?±?0.09?×?10^-3 mm²/s; P?<?0.0001). Uroepithelial malignancies can be differentiated by lowest ADC values (1.30?±?0.11?×?10^-3 mm²/s). There is a significant difference between ADC values of renal cell carcinomas and oncocytomas (1.61?±?0.08?×?10^-3 mm²/s vs 2.00?±?0.08?×?10^-3 mm²/s; P?<?0.0001).

Conclusions

Evaluation of ADC values can help to determine between benign and malignant lesions in general but also seems able to differentiate oncocytomas from malignant tumours, hence potentially reducing the number of unnecessarily performed nephrectomies.

Key Points

? This meta-analysis assesses the role of diffusion-weighted MRI in renal lesions. ? ADC values obtained by DW MRI have been compared for different renal lesions. ? ADC values can help distinguish between benign and malignant tumours. ? Differentiating oncocytomas from malignant tumours can potentially reduce inappropriate nephrectomies.     

MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies

Objective

To assess if the application of diffusion-weighted imaging (DWI) obviates unnecessary MR-guided biopsies in suspicious breast lesions visible only on contrast-enhanced MRI (CE-MRI).

Methods

This institutional review board (IRB)-approved, retrospective, single-centre study included 101 patients (mean age, 49.5; SD 13.9 years) who underwent additional DWI at 1.5 T prior to MRI-guided biopsy of 104 lesions classified as suspicious for malignancy and visible on CE-MRI only. An experienced radiologist, blinded to histopathologic and follow-up results, measured apparent diffusion coefficient (ADC) values obtained from DWI. Diagnostic accuracy was investigated using receiver operating characteristics (ROC) analysis.

Results

Histopathology revealed 20 malignant and 84 benign lesions. Lesions were masses in 61 (15 malignant, 24.6 %) and non-masses in 43 cases (five malignant, 11.6 %). Mean ADC values were 1.53?±?0.38?×?10^?3 mm²/s in benign lesions and 1.06?±?0.27?×?10^?3 mm²/s in malignant lesions. ROC analysis revealed exclusively benign lesions if ADC values were greater than 1.58?×?10^?3 mm²/s. As a consequence, 29 false-positive biopsies (34.5 %) could have been avoided without any false-negative findings. Both in mass and in non-mass lesions, rule-in and rule-out criteria were identified using flexible ADC thresholds based on ROC analysis.

Conclusion

Additional application of DWI in breast lesions visible only on MRI can avoid false-positive, MR-guided biopsies. Thus, DWI should be an integral part of breast MRI protocols.

Key Points

? DWI measurements are a fast and helpful technique for improved breast lesion diagnosis ? DWI application in breast lesions visible only on MRI obviates false-positive, MR-guided biopsies ? Flexible ADC thresholds provide rule-in and rule-out criteria for breast lesion malignancy     

Comparison of ASL and DCE MRI for the non-invasive measurement of renal blood flow: quantification and reproducibility

Objectives

To investigate the reproducibility of arterial spin labelling (ASL) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and quantitatively compare these techniques for the measurement of renal blood flow (RBF).

Methods

Sixteen healthy volunteers were examined on two different occasions. ASL was performed using a multi-TI FAIR labelling scheme with a segmented 3D-GRASE imaging module. DCE MRI was performed using a 3D-FLASH pulse sequence. A Bland-Altman analysis was used to assess repeatability of each technique, and determine the degree of correspondence between the two methods.

Results

The overall mean cortical renal blood flow (RBF) of the ASL group was 263?±?41 ml min^?1 [100 ml tissue]^?1, and using DCE MRI was 287?±?70 ml min^?1 [100 ml tissue]^?1. The group coefficient of variation (CV_g) was 18 % for ASL and 28 % for DCE-MRI. Repeatability studies showed that ASL was more reproducible than DCE with CV_gs of 16 % and 25 % for ASL and DCE respectively. Bland-Altman analysis comparing the two techniques showed a good agreement.

Conclusions

The repeated measures analysis shows that the ASL technique has better reproducibility than DCE-MRI. Difference analysis shows no significant difference between the RBF values of the two techniques.

Key Points

? Reliable non-invasive monitoring of renal blood flow is currently clinically unavailable. ? Renal arterial spin labelling MRI is robust and repeatable. ? Renal dynamic contrast-enhanced MRI is robust and repeatable. ? ASL blood flow values are similar to those obtained using DCE-MRI.     

Low contrast media volume in pre-TAVI CT examinations

Purpose

To evaluate image quality using reduced contrast media (CM) volume in pre-TAVI assessment.

Methods

Forty-seven consecutive patients referred for pre-TAVI examination were evaluated. Patients were divided into two groups: group 1 BMI?<?28 kg/m² (n?=?29); and group 2 BMI?>?28 kg/m² (n?=?18). Patients received a combined scan protocol: retrospective ECG-gated helical CTA of the aortic root (80kVp) followed by a high-pitch spiral CTA (group 1: 70 kV; group 2: 80 kVp) from aortic arch to femoral arteries. All patients received one bolus of CM (300 mgI/ml): group 1: volume?=?40 ml; flow rate?=?3 ml/s, group 2: volume?=?53 ml; flow rate?=?4 ml/s. Attenuation values (HU) and contrast-to-noise ratio (CNR) were measured at the levels of the aortic root (helical) and peripheral arteries (high-pitch). Diagnostic image quality was considered sufficient at attenuation values > 250HU and CNR > 10.

Results

Diagnostic image quality for TAVI measurements was obtained in 46 patients. Mean attenuation values and CNR (HU?±?SD) at the aortic root (helical) were: group 1: 381?±?65HU and 13?±?8; group 2: 442?±?68HU and 10?±?5. At the peripheral arteries (high-pitch), mean values were: group 1: 430?±?117HU and 11?±?6; group 2: 389?±?102HU and 13?±?6.

Conclusion

CM volume can be substantially reduced using low kVp protocols, while maintaining sufficient image quality for the evaluation of aortic root and peripheral access sites.

Key points

? Image quality could be maintained using low kVp scan protocols. ? Low kVp protocols reduce contrast media volume by 34–67 %. ? Less contrast media volume lowers the risk of contrast-induced nephropathy.

     

FDG uptake at the bronchial stump after curative lobectomy for non-small cell lung cancer

Purpose

Focal areas of FDG uptake may occur at the bronchial stump following curative lobectomy for non-small-cell lung carcinoma (NSCLC), even in the absence of suspicious CT changes. The purpose of our study was to investigate the significance of such PET/CT findings.

Methods

FDG-PET/CT scans performed in 54 patients after lobectomy for NSCLC were reviewed. The presence of focal areas of FDG uptake at the bronchial stump, associated CT abnormalities, SUVmax, and normalized SUV (SUVnorm = SUVmax/mean liver SUV) were recorded. Final diagnosis was based on biopsy or imaging follow-up.

Results

Focal areas of FDG uptake at the bronchial stump were detected in 30 patients (56 %). Mean SUVmax was 4.0?±?1.9 (range; 2.2–12.1) and mean SUVnorm was 1.8?±?0.8 (range; 0.9–4.5). Biopsy showed recurrence in two patients. In these patients, SUVnorm was respectively 4.4 and 4.5 (with SUVmax of 8.8 and 12.1), whereas SUVnorm was lower than 4.0 in those without recurrence, with mean SUVnorm of 1.6?±?0.5 (range; 0.9–3.4) and mean SUVmax of 3.6?±?0.9 (range; 2.2–5.8). The CT component of the PET/CT revealed ill-defined peribronchial soft tissue opacity only in both patients with recurrence.

Conclusion

FDG uptake at the bronchial stump is a frequent finding after pulmonary lobectomy. Moderate levels of FDG uptake (i.e., SUVnorm?<?4.0) without corresponding abnormal CT findings might be a dual criterion for diagnosing benign post-surgical changes.

     

Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)

Purpose

To compare the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo).

Methods

MoCo PET/DCE-MRI of the upper abdomen was acquired in 44 consecutive oncologic patients and compared with non-MoCo PET/MRI. SUVmax and MTV of FDG-avid upper abdominal malignant lesions were assessed on MoCo and non-MoCo PET images. Image quality was compared between MoCo DCE-MRI and non-MoCo CE-MRI, and between fused MoCo PET/MRI and fused non-MoCo PET/MRI images.

Results

MoCo PET resulted in higher SUVmax (10.8?±?5.45) than non-MoCo PET (9.62?±?5.42) and lower MTV (35.55?±?141.95 cm³) than non-MoCo PET (38.11?±?198.14 cm³; p?<?0.005 for both). The quality of MoCo DCE-MRI images (4.73?±?0.5) was higher than that of non-MoCo CE-MRI images (4.53±0.71; p?=?0.037). The quality of fused MoCo-PET/MRI images (4.96?±?0.16) was higher than that of fused non-MoCo PET/MRI images (4.39?±?0.66; p?<?0.005).

Conclusion

MoCo PET/MRI provided qualitatively better images than non-MoCo PET/MRI, and upper abdominal malignant lesions demonstrated higher SUVmax and lower MTV on MoCo PET/MRI.

     

Voxel-wise correlation of functional imaging parameters in HNSCC patients receiving PET/MRI in an irradiation setup

Purpose

The purpose of this study was to demonstrate the feasibility of voxel-wise multiparametric characterization of head and neck squamous cell carcinomas (HNSCC) using hybrid multiparametric magnetic resonance imaging and positron emission tomography with [¹⁸F]-fluorodesoxyglucose (FDG-PET/MRI) in a radiation treatment planning setup.

Methods

Ten patients with locally advanced HNSCC were examined with a combined FDG-PET/MRI in an irradiation planning setup. The multiparametric imaging protocol consisted of FDG-PET, T2-weighted transverse short tau inversion recovery sequence (STIR) and diffusion-weighted MRI (DWI). Primary tumours were manually segmented and quantitative imaging parameters were extracted. PET standardized uptake values (SUV) and DWI apparent diffusion coefficients (ADC) were correlated on a voxel-wise level.

Results

Images acquired in this specialised radiotherapy planning setup achieved good diagnostic quality. Median tumour volume was 4.9 [1.1–42.1]?ml. Mean PET SUV and ADC of the primary tumours were 5?±?2.5 and 1.2?±?0.3 10^?3?mm²/s, respectively. In voxel-wise correlation between ADC values and corresponding FDG SUV of the tumours, a significant negative correlation was observed (r?=??0.31?±?0.27, p?<?0.05).

Conclusion

Multiparametric voxel-wise characterization of HNSCC is feasible using combined PET/MRI in a radiation planning setup. This technique may provide novel insights into tumour biology with regard to radiation therapy in the future.

     

18F-FDG uptake in breast cancer correlates with immunohistochemically defined subtypes

Objectives

To determine whether a correlation exists between maximum standardized uptake value (SUV_max) on ¹⁸F-fluorodeoxyglucose positron emission tomography (FDG-PET) and the subtypes of breast cancer.

Methods

This retrospective study involved 548 patients (mean age 51.6 years, range 21–81 years) with 552 index breast cancers (mean size 2.57 cm, range 1.0–14.5 cm). The correlation between ¹⁸F-FDG uptake in PET/CT, expressed as SUV_max, and immunohistochemically defined subtypes (luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) positive and triple negative) was analyzed.

Results

The mean SUV_max value of the 552 tumours was 6.07?±?4.63 (range 0.9–32.8). The subtypes of the 552 tumours were 334 (60 %) luminal A, 66 (12 %) luminal B, 60 (11 %) HER2 positive and 92 (17 %) triple negative, for which the mean SUV_max values were 4.69?±?3.45, 6.51?±?4.18, 7.44?±?4.73 and 9.83?±?6.03, respectively. In a multivariate regression analysis, triple-negative and HER2-positive tumours had 1.67-fold (P?<?0.001) and 1.27-fold (P?=?0.009) higher SUV_max values, respectively, than luminal A tumours after adjustment for invasive tumour size, lymph node involvement status and histologic grade.

Conclusion

FDG uptake was independently associated with subtypes of invasive breast cancer. Triple-negative and HER2-positive breast cancers showed higher SUV_max values than luminal A tumours.

Key Points

? ¹⁸ F-FDG PET demonstrates increased tissue glucose metabolism, a hallmark of cancers. ? Immunohistochemically defined subtypes appear significantly associated with FDG uptake (expressed as SUV _max ). ? Triple-negative tumours had 1.67-fold higher SUV _max values than luminal A tumours. ? HER2-positive tumours had 1.27-fold higher SUV _max values than luminal A tumours.     

Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [<Superscript>18</Superscript>F]fluoro-borono-phenylalanine PET/CT

Objectives

A previous study reported that a differential diagnosis between glioblastoma progression and radiation necrosis by 4-borono-2-[¹⁸F]-fluoro-phenylalanine ([¹⁸F]FBPA) PET can be made based on lesion-to-normal ratio of [¹⁸F]FBPA accumulation. Two-dimensional data acquisition mode PET alone system, with in-plane resolution of 7.9 mm and axial resolution of 13.9 mm, was used. In the current study, we aimed to confirm the differential diagnostic capability of [¹⁸F]FBPA PET/CT with higher PET spatial resolution by three-dimensional visual inspection and by measuring mean standardized uptake value (SUVmean), maximum SUV (SUVmax), metabolic tumor volume (MTV), and total lesion (TL) [¹⁸F]FBPA uptake.

Methods

Twelve patients of glioma (9), malignant meningioma (1), hemangiopericytoma (1), and metastatic brain tumor (1) were enrolled. All had preceding radiotherapy. High-resolution three-dimensional data acquisition mode PET/CT with in-plane resolution of 4.07 mm and axial resolution of 5.41 mm was employed for imaging. Images were three-dimensionally analyzed using the PMOD software. SUVmean and SUVmax of lesion and normal brain were measured. Lesion MTV and TL FBPA uptake were calculated. The diagnostic accuracy of [¹⁸F]FBPA PET/CT in detecting recurrence (n?=?6) or necrosis (n?=?6) was verified by clinical follow-up.

Results

All parameters showed significantly higher values for tumor recurrence than for necrosis. SUVmean in recurrence was 2.95?±?0.84 vs 1.18?±?0.24 in necrosis (P?=?0.014); SUVmax in recurrence was 4.63?±?1.23 vs 1.93?±?0.44 in necrosis (P?=?0.014); MTV in recurrence was 44.92?±?28.93 mL vs 10.66?±?8.46 mL in necrosis (P?=?0.032); and mean TL FBPA uptake in recurrence was 121.01?±?50.48 g vs 12.36?±?9.70 g in necrosis (P?=?0.0029).

Conclusion

In this preliminary feasibility study, we confirmed the possibility of differentiating tumor recurrence from radiation necrosis in patients with irradiated brain tumors by [¹⁸F]FBPA PET/CT using indices of SUVmean, SUVmax, MTV, and TL ¹⁸FBPA uptake.

     

Developmental associations with muscle morphology,physical performance,and asymmetry in youth judo athletes

Purpose

This study evaluated the contributions of somatic maturity (years from estimated peak height velocity) and training experience as developmental indicators of muscle morphology, biomechanical parameters, and bilateral asymmetries in youth judo athletes.

Methods

Twenty-six judo athletes aged 8–18 years (mean?±?SD; age?=?12.9?±?2.6 years, maturity offset = ? 0.6?±?2.2 years, training experience?=?6.1?±?2.9 years) completed anthropometric measurements, performance testing, and ultrasound evaluation of the vastus lateralis.

Results

Somatic maturity had the greatest relationship with handgrip performance (r²?=?0.76–0.80; p?<?0.01) and lower-body plyometric ability (r²?=?0.23–0.72; p?<?0.05). Somatic maturity and training experience accounted for 72% of the variance in hopping power. Bilateral asymmetries in average/peak force and 1-/2-s force–time integration during isometric handgrip increased with training experience (r²?=?0.17–0.46 p?<?0.05). Muscle morphology (r²?=?0.29–0.75; p?<?0.01) was best related to somatic maturity. Significant differences were found between child and adolescent judo athletes in force–time curve parameters, muscle morphology, and plyometric ability.

Conclusions

These results indicate that somatic maturity and training experience exert unique influences on muscle morphology, biomechanical parameters, and bilateral asymmetries in youth judo athletes.

     

Basal <Superscript>18</Superscript> F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography as a prognostic biomarker in patients with locally advanced breast cancer

Aim

To explore the relationship between basal ¹⁸?F-FDG PET/CT information in breast tumours and survival in locally advanced breast cancer (LABC).

Methods

This prospective, multicentre study included 198 women diagnosed with LABC. All patients underwent ¹⁸?F-FDG PET/CT prior to treatment. The maximum standardized uptake value (SUVmax) in tumor (T), lymph nodes (N) and the N/T ratio was obtained in all cases. Stage according to PET/CT imaging (metabolic stage) and conventional imaging techniques (clinical stage) was established. During follow-up, patient status was established (disease free status or not). The relationship between all the variables and overall survival (OS) and disease-free survival (DFS) was analysed using the Kaplan-Meier and Cox regression methods. A ROC analysis was performed to obtain a cut-off value of SUVmax that was useful in the prediction of outcome.

Results

The mean SUVmax?±?SD values in the primary tumour, lymph nodes and the SUVmax N/T index were 7.40?±?5.57, 4.17?±?4.74 and 0.73?±?1.20, respectively. Higher semiquantitative metabolic values were found in more advanced metabolic and clinical stages. During follow-up, 78.4 % of patients were free of disease. Significant relationships were observed between SUVT and SUVN and patient status. With respect to OS and DFS, significant differences were detected for the metabolic stage. Kaplan-Meier analysis revealed that using the cut-off values, a primary-tumour SUVmax?≥?6.05 or a nodal SUVmax ≥2.25 were significantly correlated with DFS and OS.

Conclusion

PET imaging with ¹⁸?F-FDG offers prognostic information for LABC that can be obtained preoperatively and noninvasively

     

Diagnostic performance of 18F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with 18F-fluorodeoxyglucose PET/CT

Purpose

To examine the diagnostic performance of ¹⁸F-fluorothymidine (FLT) PET/CT in primary and metastatic lymph node colorectal cancer foci in comparison with ¹⁸F-fluorodeoxyglucose (FDG) PET/CT.

Methods

The study population comprised 28 patients with 30 newly diagnosed colorectal cancers who underwent surgical resection of the primary lesion and regional lymph nodes after both FLT and FDG PET/CT. The associations between SUVmax levels and pathological factors were evaluated using the Mann-Whitney U or Kruskal-Wallis test. Differences in diagnostic indexes for detecting nodal metastasis between the two tracers were estimated using the McNemar exact or χ ² test.

Results

All 30 primary cancers (43.0?±?20.0 mm, range 14 – 85 mm) were visualized by both tracers, but none of the FLT SUVmax values exceeded the FDG SUVmax values in any of the primary cancers (6.6?±?2.4 vs. 13.6?±?5.8, p?<?0.001). The sensitivity, specificity and accuracy for detecting nodal metastasis were 41 % (15/37), 98.8 % (493/499) and 94.8 % (508/536) for FDG PET/CT, and 32 % (12/37), 98.8 % (493/499) and 94.2 % (505/536) for FLT PET/CT, respectively. The sensitivity (p?=?0.45), specificity (p?=?0.68) and accuracy (p?=?0.58) were not different between the tracers. Nodal uptake of FLT and FDG was discordant in 7 (19 %) of 37 metastatic nodes. There were ten concordant true-positive nodes of which six showed higher FDG SUVmax and four showed higher FLT SUVmax, but the difference between FDG and FLT SUVmax was not significant (5.56?±?3.55 and 3.62?±?1.45, respectively; p?=?0.22).

Conclusion

FLT has the same potential as FDG in PET/CT for the diagnosis of primary and nodal foci of colorectal cancer despite significantly lower FLT uptake in primary foci.     

Dose reduction in dynamic CT stress myocardial perfusion imaging: comparison of 80-kV/370-mAs and 100-kV/300-mAs protocols

Objectives

To determine the effect of reduced 80-kV tube voltage with increased 370-mAs tube current on radiation dose, image quality and estimated myocardial blood flow (MBF) of dynamic CT stress myocardial perfusion imaging (CTP) in patients with a normal body mass index (BMI) compared with a 100-kV and 300-mAs protocol.

Methods

Thirty patients with a normal BMI (<25 kg/m²) with known or suspected coronary artery disease underwent adenosine-stress dual-source dynamic CTP. Patients were randomised to 80-kV/370-mAs (n?=?15) or 100-kV/300-mAs (n?=?15) imaging. Maximal enhancement and noise of the left ventricular (LV) cavity, contrast-to-noise ratio (CNR) and MBF of the two groups were compared.

Results

Imaging with 80-kV/370-mAs instead of 100-kV/300-mAs was associated with 40 % lower radiation dose (mean dose–length product, 359?±?66 vs 628?±?112 mGy?cm; P?<?0.001 ) with no significant difference in CNR (34.5?±?13.4 vs 33.5?±?10.4; P?=?0.81) or MBF in non-ischaemic myocardium (0.95?±?0.20 vs 0.99?±?0.25 ml/min/g; P?=?0.66). Studies obtained using 80-kV/370-mAs were associated with 30.9 % higher maximal enhancement (804?±?204 vs 614?±?115 HU; P?<?0.005), and 31.2 % greater noise (22.7?±?3.5 vs 17.4?±?2.6; P?<?0.001).

Conclusions

Dynamic CTP using 80-kV/370-mA instead of 100-kV/300-mAs allowed 40 % dose reduction without compromising image quality or MBF. Tube voltage of 80-kV should be considered for individuals with a normal BMI.

Key Points

? CT stress perfusion imaging (CTP) is increasingly used to assess myocardial function. ? Dynamic CTP is feasible at 80-kV in patients with normal BMI. ? An 80-kV/370-mAs protocol allows 40 % dose reduction compared with 100-kV/300-mAs. ? Contrast-to-noise ratio and myocardial blood flow of the two protocols were comparable.